When DND1 is knocked down in breast cancer cells, it promotes the decline of BIM mRNA due to the increased binding of miR-221 to the Bim-3’UTR, thereby inhibiting apoptosis or leading to a poor prognosis in breast cancer patients. This evidence concerns the gene BCL2L11 and breast carcinoma.